UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HiPSC-Derived Hepatocyte-like Cells Can Be Used as a Model for Transcriptomics-Based Study of Chemical Toxicity

Toxics (Basel), 2021-12, Vol.10 (1), p.1

2021

Volltextzugriff (PDF)

Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice

PLoS biology, 2011-12, Vol.9 (12), p.e1001212

2011

Volltextzugriff (PDF)

Dysregulation of a long noncoding RNA reduces leptin leading to a leptin-responsive form of obesity

Nature medicine, 2019-03, Vol.25 (3), p.507-516

2019

Volltextzugriff (PDF)

School-based interventions modestly increase physical activity and cardiorespiratory fitness but are least effective for youth who need them most: an individual participant pooled analysis of 20 controlled trials

British journal of sports medicine, 2021-07, Vol.55 (13), p.721-729

2021

Volltextzugriff (PDF)

Intrinsic disorder is a common feature of hub proteins from four eukaryotic interactomes

PLoS computational biology, 2006-08, Vol.2 (8), p.e100-e100

2006

Volltextzugriff (PDF)

Chronic consumption of farmed salmon containing persistent organic pollutants causes insulin resistance and obesity in mice

PloS one, 2011-09, Vol.6 (9), p.e25170

2011

Volltextzugriff (PDF)

CTCF chromatin residence time controls three-dimensional genome organization, gene expression and DNA methylation in pluripotent cells

Nature cell biology, 2021-08, Vol.23 (8), p.881-893

2021

Volltextzugriff (PDF)

Edgetic perturbation models of human inherited disorders

Molecular systems biology, 2009, Vol.5 (1), p.321-n/a

2009

Volltextzugriff (PDF)

Interactome: gateway into systems biology

Human molecular genetics, 2005-10, Vol.14 (suppl-2), p.R171-R181

2005

Volltextzugriff (PDF)

Novel Combinations of Immunotherapies or DNA Damage Repair Inhibitors in Platinum-Refractory Extensive-Stage Small Cell Lung Cancer: The Phase II BALTIC Study

Clinical cancer research, 2024-09, Vol.30 (18), p.4055-4067

2024

Volltextzugriff (PDF)

Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses

Retrovirology, 2012-03, Vol.9 (1), p.26-26, Article 26

2012

Volltextzugriff (PDF)

Influence of Farming Intensity and Climate on Lowland Stream Nitrogen

Water (Basel), 2020-04, Vol.12 (4), p.1021

2020

Volltextzugriff (PDF)

TREM2 expression in the brain and biological fluids in prion diseases

Acta neuropathologica, 2021-06, Vol.141 (6), p.841-859

2021

Volltextzugriff (PDF)

Oncostatin M Reduces Lesion Size and Promotes Functional Recovery and Neurite Outgrowth After Spinal Cord Injury

Molecular neurobiology, 2014-12, Vol.50 (3), p.1142-1151

2014

Volltextzugriff (PDF)

Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial

Journal for immunotherapy of cancer, 2024-02, Vol.12 (2), p.e008189

2024

Volltextzugriff (PDF)

Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma

Nature genetics, 2011-11, Vol.43 (11), p.1131-1138

2011

Volltextzugriff (PDF)

Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial

European journal of cancer (1990), 2024-11, Vol.211, p.114296, Article 114296

2024

Volltextzugriff (PDF)

Five-year outcomes with first-line (1L) nivolumab + ipilimumab + chemotherapy (N + I + C) vs C in patients (pts) with metastatic NSCLC (mNSCLC) in CheckMate 9LA

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.8560-8560

2024

Volltextzugriff (PDF)

Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial

The lancet respiratory medicine, 2023-01, Vol.11 (1), p.74-86

2023

Volltextzugriff (PDF)

Dispersion Anisotropy of Plasmon–Exciton–Polaritons in Lattices of Metallic Nanoparticles

ACS photonics, 2018-01, Vol.5 (1), p.233-239

2018

Volltextzugriff (PDF)

First-line (1L) nivolumab (N) + ipilimumab (I) + chemotherapy (C) vs C alone in patients (pts) with metastatic NSCLC (mNSCLC) from CheckMate 9LA: 4-y clinical update and outcomes by tumor histologic subtype (THS)

Journal of clinical oncology, 2023-06, Vol.41 (17_suppl), p.LBA9023-LBA9023

2023

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(48)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

HiPSC-Derived Hepatocyte-like Cells Can Be Used as a Model for Transcriptomics-Based Study of Chemical Toxicity

LRRC37B is a human modifier of voltage-gated sodium channels and axon excitability in cortical neurons

Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice

Dysregulation of a long noncoding RNA reduces leptin leading to a leptin-responsive form of obesity

School-based interventions modestly increase physical activity and cardiorespiratory fitness but are least effective for youth who need them most: an individual participant pooled analysis of 20 controlled trials

Intrinsic disorder is a common feature of hub proteins from four eukaryotic interactomes

Chronic consumption of farmed salmon containing persistent organic pollutants causes insulin resistance and obesity in mice

CTCF chromatin residence time controls three-dimensional genome organization, gene expression and DNA methylation in pluripotent cells

Edgetic perturbation models of human inherited disorders

Empirically controlled mapping of the Caenorhabditis elegans protein-protein interactome network

Interactome: gateway into systems biology

First-Line Nivolumab Plus Ipilimumab With Chemotherapy Versus Chemotherapy Alone for Metastatic NSCLC in CheckMate 9LA: 3-Year Clinical Update and Outcomes in Patients With Brain Metastases or Select Somatic Mutations

An empirical framework for binary interactome mapping

Novel Combinations of Immunotherapies or DNA Damage Repair Inhibitors in Platinum-Refractory Extensive-Stage Small Cell Lung Cancer: The Phase II BALTIC Study

Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses

Influence of Farming Intensity and Climate on Lowland Stream Nitrogen

TREM2 expression in the brain and biological fluids in prion diseases

Oncostatin M Reduces Lesion Size and Promotes Functional Recovery and Neurite Outgrowth After Spinal Cord Injury

Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial

Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma

Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial

Five-year outcomes with first-line (1L) nivolumab + ipilimumab + chemotherapy (N + I + C) vs C in patients (pts) with metastatic NSCLC (mNSCLC) in CheckMate 9LA

Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial

Dispersion Anisotropy of Plasmon–Exciton–Polaritons in Lattices of Metallic Nanoparticles

First-line (1L) nivolumab (N) + ipilimumab (I) + chemotherapy (C) vs C alone in patients (pts) with metastatic NSCLC (mNSCLC) from CheckMate 9LA: 4-y clinical update and outcomes by tumor histologic subtype (THS)

Suchergebnisse filtern